Boston Scientific Corp. (BSX)

41.81
NYSE : Health Technology
Prev Close 42.24
Day Low/High 41.56 / 42.45
52 Wk Low/High 31.56 / 43.84
Avg Volume 5.61M
Exchange NYSE
Shares Outstanding 1.39B
Market Cap 58.84B
EPS 1.20
P/E Ratio 42.16
Div & Yield N.A. (N.A)
Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

NEW YORK, April 23, 2019 /PRNewswire/ -- Advanced Disposal Services, Inc. (ADSW) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ADSW to Waste Management, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

NEW YORK, April 19, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).

Boston Scientific Announces Conference Call Discussing First Quarter 2019 Financial Results

Boston Scientific Announces Conference Call Discussing First Quarter 2019 Financial Results

MARLBOROUGH, Mass., March 27, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2019 on Wednesday, April 24, 2019 at...

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.

Shire, Abbott Labs May Pace Healthcare Stocks in 2019

Shire, Abbott Labs May Pace Healthcare Stocks in 2019

Healthcare has been the best performing sector of the market this year. Here are three buy-rated stocks to track now.

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

Jim Cramer says most - but not all - stocks are in a bear market. He talks about what's happening with Clorox, Coca-Cola, Verizon, Apple and more.

Analog Devices, MongoDB, Welltower: 'Mad Money' Lightning Round

Analog Devices, MongoDB, Welltower: 'Mad Money' Lightning Round

Jim Cramer takes a look at Analog Devices, MongoDB, Welltower, Ventas, Iridium Communications, Huntington Bancshares, Citigroup, Randgold Resources and more.

Boston Scientific to Buy Britain's BTG for $4.2 Billion

Boston Scientific to Buy Britain's BTG for $4.2 Billion

Boston Scientific offered $10.77 for each BTG share, valuing the company at $4.2 billion.

FAANGs, Retail, Housing, Boston Scientific & Renault - Five Things You Must Know

FAANGs, Retail, Housing, Boston Scientific & Renault - Five Things You Must Know

FAANG stocks are sliding into bear market territory, retail earnings dominate today's corporate calendar, housing starts and building permits will test US rate hike bets, Boston Scientific makes $4.2 billion U.K. play and Carlos Ghosn could be left by the roadside - Five Things You Must Know Before the Bell.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Here's Why the Market Rally Has Staying Power

Jim Cramer: Here's Why the Market Rally Has Staying Power

For most of this year the market has been led by growth stocks.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

How Boston Scientific Call Prices Rose Eightfold

How Boston Scientific Call Prices Rose Eightfold

The Healthcare sector has seen a revitalization year-to-date, and these investors may have wanted to participate in a continued move higher, risking a fraction of the price of a share in the event they were 'late to the party.'

3 Biotech Stock Favorites to Bet on Today: Top Analysts

3 Biotech Stock Favorites to Bet on Today: Top Analysts

Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.

Stryker Says Not in Talks to Buy Boston Scientific

Stryker Says Not in Talks to Buy Boston Scientific

The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. averages closed the day in the green Monday.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.

Boston Scientific Jumps on Report of Stryker Takeover Approach

Boston Scientific Jumps on Report of Stryker Takeover Approach

The Wall Street Journal reports Stryker made a takeover approach for the medical device company.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

The insurgent manager who helped engineer the Amazon-Whole Foods combination opened a window into his latest allocations, any of which could become campaigns. Here's a wrap up of his investments as well as new developments from Mick McGuire's Marcato Capital and Dan Loeb's Third Point.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, APU, EBR, FNCB, TROW Downgrades: BSX, HLF, IROQ, KR, KWR, LABL, LLY, NX Initiations: AQN Read on to get TheStreet Quant Ratings' detailed report:

Quants and Charts Agree That Boston Scientific is a Buy

Quants and Charts Agree That Boston Scientific is a Buy

Boston Scientific shares are poised for more gains

TheStreet Quant Rating: B (Buy)